Comparative glycosylation mapping of plasma-derived and recombinant human factor VIII
Open Access
- 22 May 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (5), e0233576
- https://doi.org/10.1371/journal.pone.0233576
Abstract
Human coagulation factor VIII (FVIII) is a key co-factor in the clotting cascade, the deficiency of which leads to Hemophilia A. Human plasma-derived (pdFVIII) and recombinant FVIII (rFVIII) had been used as effective products to prevent and treat bleeding episodes. Both FVIII products share identical amino acid sequences and appear to be equivalent as of clinical efficiency. However, systemic reviews found an increased risk of neutralizing antibody (or inhibitor) development with recombinant products. FVIII is a highly glycosylated protein, and its glycosylation pattern is specific to host cells and environments. The roles of glycosylation in immune responses toward pdFVIII and rFVIII are yet to be defined. Herein, we systemically profiled N- and O-glycomes of pdFVIII and rFVIII using a mass spectrometry-based glycoproteomic strategy. A total of 110 site-specific N-glycopeptides consisting of 61 N-glycoforms were identified quantitatively from rFVIII and pdFVIII. Additionally, 31 O-glycoforms were identified on 23 peptides from rFVIII and pdFVIII. A comprehensive comparison of their site-specific glycan profiles revealed distinct differences between the glycosylation of pdFVIII and rFVIII.This publication has 42 references indexed in Scilit:
- Improved Peptide Identification by Targeted Fragmentation Using CID, HCD and ETD on an LTQ-Orbitrap VelosJournal of Proteome Research, 2011
- Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteinsNature Biotechnology, 2010
- Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A miceBlood, 2009
- Effects of glycosylation on the stability of protein pharmaceuticalsJournal of Pharmaceutical Sciences, 2009
- A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytesProceedings of the National Academy of Sciences of the United States of America, 2007
- VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectorsBlood, 2006
- Structure and Function of the Factor VIII Gene and ProteinSeminars in Thrombosis and Hemostasis, 2003
- Detailed peptide characterization using PEPTIDEMASS – a World‐Wide‐Web‐accessible toolElectrophoresis, 1997
- The physiology and pathophysiology of the factor VIII complexCritical Reviews in Oncology/Hematology, 1986
- Factor VIII: Structure and function in blood clottingAmerican Journal of Hematology, 1984